Community-based multi-disease prevention campaigns for controlling human immunodeficiency virus-associated tuberculosis

被引:4
作者
Suthar, A. B. [1 ]
Klinkenberg, E. [2 ]
Ramsay, A. [3 ]
Garg, N. [4 ]
Bennett, R.
Towle, M.
Sitienei, J. [5 ]
Smyth, C.
Daniels, C. [6 ]
Baggaley, R.
Gunneberg, C. [6 ]
Williams, B. [7 ]
Getahun, H. [6 ]
van Gorkom, J. [2 ]
Granich, R. M.
机构
[1] WHO, Antiretroviral Treatment & HIV Care Unit, Dept HIV AIDS, CH-1211 Geneva 27, Switzerland
[2] KNCV TB Fdn, The Hague, Netherlands
[3] WHO, Special Programme Res & Training Trop Dis, CH-1211 Geneva 27, Switzerland
[4] Vestergaard Frandsen Inc, Lausanne, Switzerland
[5] Kenya Minist Publ Hlth & Sanitat, Div Leprosy TB & Lung Dis, Nairobi, Kenya
[6] WHO, Stop TB Dept, CH-1211 Geneva 27, Switzerland
[7] Univ Stellenbosch, S African Ctr Epidemiol Modelling & Anal, ZA-7600 Stellenbosch, South Africa
关键词
tuberculosis; HIV; control; campaign; community; ANTIRETROVIRAL THERAPY; HIV CARE; STRATEGIES; ADULTS; ERADICATION; MORTALITY; ZIMBABWE; PROGRAM; ACCESS; IMPACT;
D O I
10.5588/ijtld.11.0480
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Human immunodeficiency virus (HIV) infection increases the risk of tuberculosis (TB) 21-34 fold, and has fuelled the resurgence of TB in sub-Saharan Africa. The World Health Organization (WHO) recommends the Three I's for HIV/TB (infection control, intensified case finding [ICF] and isoniazid preventive therapy) and earlier initiation of antiretroviral therapy for preventing TB in persons with HIV. Current service delivery frameworks do not identify people early enough to maximally harness the preventive benefits of these interventions. Community-based campaigns were essential components of global efforts to control major public health threats such as polio, measles, guinea worm disease and smallpox. They were also successful in helping to control TB in resource-rich settings. There have been recent community-based efforts to identify persons who have TB and/or HIV. Multi-disease community-based frameworks have been rare. Based on findings from a WHO meta-analysis and a Cochrane review, integrating ICF into the recent multi-disease prevention campaign in Kenya may have had implications in controlling TB. Community-based multi-disease prevention campaigns represent a potentially powerful strategy to deliver prevention interventions, identify people with HIV and/or TB, and link those eligible to care and treatment.
引用
收藏
页码:430 / 436
页数:7
相关论文
共 50 条
  • [21] The accelerated simian immunodeficiency virus macaque model of human immunodeficiency virus-associated neurological disease: From mechanism to treatment
    Clements, Janice E.
    Mankowski, Joseph L.
    Gama, Lucio
    Zink, M. Christine
    JOURNAL OF NEUROVIROLOGY, 2008, 14 (04) : 309 - 317
  • [22] Clinical features and treatment interventions for human immunodeficiency virus-associated neurologic disease in children
    Mintz, M
    SEMINARS IN NEUROLOGY, 1999, 19 (02) : 165 - 176
  • [23] Predictors of mortality in adults on treatment for human immunodeficiency virus-associated tuberculosis in Botswana: A retrospective cohort study
    Muyaya, Ley Muyaya
    Young, Taryn
    Loveday, Marian
    MEDICINE, 2018, 97 (16)
  • [24] Clinical Predictors of Liver Fibrosis Presence and Progression in Human Immunodeficiency Virus-Associated Nonalcoholic Fatty Liver Disease
    Fourman, Lindsay T.
    Stanley, Takara L.
    Zheng, Isabel
    Pan, Chelsea S.
    Feldpausch, Meghan N.
    Purdy, Julia
    Aepfelbacher, Julia
    Buckless, Colleen
    Tsao, Andrew
    Corey, Kathleen E.
    Chung, Raymond T.
    Torriani, Martin
    Kleiner, David E.
    Hadigan, Colleen M.
    Grinspoon, Steven K.
    CLINICAL INFECTIOUS DISEASES, 2021, 72 (12) : 2087 - 2094
  • [25] The epidemiology of human immunodeficiency virus-associated neurological disease in the era of highly active antiretroviral therapy
    Sacktor, N
    JOURNAL OF NEUROVIROLOGY, 2002, 8 : 115 - 121
  • [26] Human Immunodeficiency Virus-associated Immune Complex Kidney Disease Progressing to End-stage Kidney Disease
    Shichijo, Yuka
    Harada, Ko
    Ward, Stephen C.
    Harbord, Nikolas
    INTERNAL MEDICINE, 2023, 62 (21) : 3183 - 3186
  • [27] HUMAN IMMUNODEFICIENCY VIRUS-ASSOCIATED PROSTATE CANCER: CLINICOPATHOLOGICAL FINDINGS AND OUTCOME IN A MULTI-INSTITUTIONAL STUDY
    Ghani, Khurshid R. .
    Oliver, R. Tim D.
    Chinegwundoh, Frank
    BJU INTERNATIONAL, 2009, 103 (02) : 270 - 271
  • [28] Human immunodeficiency virus-associated prostate cancer: clinicopathological findings and outcome in a multi-institutional study
    Pantanowitz, Liron
    Bohac, Gerry
    Cooley, Timothy P.
    Aboulafia, David
    Dezube, Bruce J.
    BJU INTERNATIONAL, 2008, 101 (12) : 1519 - 1523
  • [29] Human Immunodeficiency Virus Is the Major Determinant of Steatosis and Hepatitis C Virus of Insulin Resistance in Virus-associated Fatty Liver Disease
    Guaraldi, Giovanni
    Lonardo, Amedeo
    Ballestri, Stefano
    Zona, Stefano
    Stentarelli, Chiara
    Orlando, Gabriella
    Carli, Federica
    Carulli, Lucia
    Roverato, Alberto
    Loria, Paola
    ARCHIVES OF MEDICAL RESEARCH, 2011, 42 (08) : 690 - 697
  • [30] Human Immunodeficiency Virus-Associated Primary Lung Cancer in the Era of Highly Active Antiretroviral Therapy: A Multi-Institutional Collaboration
    D'Jaen, Gabriela A.
    Pantanowitz, Liron
    Bower, Mark
    Buskin, Susan
    Neil, Nancy
    Greco, Erin M.
    Cooley, Timothy P.
    Henry, David
    Stem, Jonathan
    Dezube, Bruce J.
    Stebbing, Justin
    Aboulafia, David M.
    CLINICAL LUNG CANCER, 2010, 11 (06) : 396 - 404